Article
Detection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancer.
Journal of translational medicine - 18 Dec 2010
Simonetti Sara, Molina Miguel Angel, Queralt Cristina, de Aguirre Itziar, Mayo Clara, Bertran-Alamillo Jordi, Sanchez José Javier, Gonzalez-Larriba Jose Luis, Jimenez Ulpiano, Isla Dolores, Moran Teresa, Viteri Santiago, Camps Carlos, Garcia-Campelo Rosario, Massuti Bartomeu, Benlloch Susana, Ramon y Cajal Santiago, Taron Miquel, Rosell Rafael
Abstract excerpt
BACKGROUND: Immunohistochemistry (IHC) with mutation-specific antibodies may be an ancillary method of detecting EGFR mutations in lung cancer patients. METHODS: EGFR mutation status was analyzed by DNA assays, and compared with IHC results in five non-small-cell lung cancer (NSCLC) cell lines an...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
